08:00 , Jan 6, 2014 |  BC Week In Review  |  Company News

Columbia Laboratories, AstraZeneca, U.K. Technology Strategy Board (TSB) drug delivery news

On Dec. 19, 2013, Columbia's Molecular Profiles Ltd. subsidiary joined a U.K. consortium led by AstraZeneca and announced a £660,000 ($1.1 million) grant from the U.K. Technology Strategy Board to help fund the consortium's £1...
08:00 , Feb 26, 2001 |  BC Week In Review  |  Company News

Advanced Medical other research news

AMS received a £130,000 ($188,000) grant from the Fifth Research and Technological Development European Framework Programme to continue research on cell-matrix interactions. The grant will support research by AMS and the University Glasgow to develop...
08:00 , Feb 26, 1996 |  BC Week In Review  |  Company News

Aston University other research news

University researchers reported in Nature that they have isolated a proteoglycan of relative molecular mass 24K, which produces cachexia in mice by inducing catabolism of skeletal muscle. The proteoglycan was isolated in murine adenocarcinoma using...